Cas:221109-26-8 2-Phenyl-3-(4-piperidinyl)indoline manufacturer & supplier

Chemical Name:2-Phenyl-3-(4-piperidinyl)indoline

CAS.NO:221109-26-8

Synonyms:2-Phenyl-3-(4-piperidinyl)-1H-indole;1H-Indole, 2,3-dihydro-2-phenyl-3-(4-piperidinyl)-;3-(Piperidin-4-yl)-2-phenyl-1H-indole;2-Phenyl-3-(4-piperidinyl)indoline;2-PHENYL-3-(PIPERIDIN-4-YL)-1H-INDOLE

Molecular Formula:C₁₉H₂₂N₂

Molecular Weight:278.391

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:417.3±45.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.590

PSA:24.06000

Exact Mass:278.178314

LogP:3.69

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Phenyl-3-(4-piperidinyl)-1H-indole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-PHENYL-3-(PIPERIDIN-4-YL)-1H-INDOLE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Indole, 2,3-dihydro-2-phenyl-3-(4-piperidinyl)- Use and application,2-PHENYL-3-(PIPERIDIN-4-YL)-1H-INDOLE technical grade,usp/ep/jp grade.

Related News: Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. 2-Phenyl-3-(4-piperidinyl)indoline manufacturer Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. 2-Phenyl-3-(4-piperidinyl)indoline supplier However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future. 2-Phenyl-3-(4-piperidinyl)indoline vendor Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector. 2-Phenyl-3-(4-piperidinyl)indoline factory However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.